Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureSuthanthira Kannan Ramamoorthy, Tina Noutsos
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical management of bispecific antibody therapy for lymphoma: a British Society for Haematology Good Practice Paper
10.1111/bjh.70018 · 2025
Outcomes of bispecific antibodies after CAR T‐cell failure for large B‐cell lymphoma: results from the ABC consortium
10.1182/bloodadvances.2025016968 · 2026
Real world safety outcomes of an outpatient lymphoma bispecific antibody program: a single center experience from Johns Hopkins
2025
Predictive factors and nomogram for the risk of cytokine release syndrome with anti‐CD3 × CD20 bispecific antibodies for Chinese patients
2025
No additional external references are available.